Related Experiment Video
Updated: Nov 4, 2025

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis
Published on: May 12, 2020
The Evidence Base for Prevention of Infectious Bovine Keratoconjunctivitis Through Vaccination
Gabriele Maier1, Annette M O'Connor2, David Sheedy3
1Department of Population Health & Reproduction, School of Veterinary Medicine, University of California Davis, Davis, 1 Shieds Avenue, VM3B, Davis, CA 95616, USA.
Abstract:
Pili and cytotoxins are important virulence factors and antigens for Moraxella spp. Local and systemic immunity may play a role in the body's response to infectious bovine keratoconjunctivitis (IBK). No evidence exists that eliminating the carrier state for IBK is possible or beneficial. Evidence for efficacious transfer of passive immunity from dams to calves is conflicting. Autogenous vaccines and commercial vaccines for putative pathogens for IBK have not yet shown efficacy in blinded randomized field trials. Study design features, such as randomization, blinding, diagnostic criteria, and use of a placebo, reduce the risk of bias in vaccine studies for IBK.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Vaccinations

